Johnson & Johnson paying $1.75 bn for Alios BioPharma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Chemical Business NewsBase (UK), October 6, 2014, 2pp
  • Additional Information
    • Abstract:
      Johnson & Johnson (J&J) is acquiring the US biotechnology firm Alios BioPharma which specializes in the development of treatments for infectious diseases. It is prepared to pay up to $1.75 bn (EUR 1.39 bn) for Alios. The deal has already been approved by the boards of the 2 firms. It is scheduled for completion in the 4Q of 2014...